Novolog 100 unit/ML flexpen 3ML
Ended Awarded
- Contract number
- SPE2DB26FJEZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,153
Award facts
- Contract value 100% obligated
- $3,152.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.87 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of November 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company's federal contracting demonstrates significant capability in delivering specialized medications across multiple therapeutic domains, including diabetes treatments, neurological medications, and other clinical products. Through competitive procurement processes, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V regional contracts in the coming years.
Quick answers
Who was awarded contract SPE2DB26FJEZ5?
SPE2DB26FJEZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FJEZ5 worth?
The government has obligated $3,153 on SPE2DB26FJEZ5.
Is contract SPE2DB26FJEZ5 an order under another contract?
Yes. SPE2DB26FJEZ5 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB26FJEZ5 competed?
The extent of competition for SPE2DB26FJEZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award